Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1973 Sep;4(3):376–377. doi: 10.1128/aac.4.3.376

Inhibition of Mycoplasma pneumoniae by Actinomycin D

Ronald D Fletcher 1, Chinrudee Jayavasu 1, Sungwhaoh Yoo 1, John N Albertson 1
PMCID: PMC444560  PMID: 4758840

Abstract

Growth of Mycoplasma pneumoniae was completely prevented by 0.06 μg of actinomycin D/ml, and 0.00375 μg/ml caused 90% inhibition. It thus appears that M. pneumoniae is more susceptible to actinomycin D than previously reported. Low concentrations (0.019 μg/ml) of the antibiotic primarily inhibited ribonucleic acid synthesis and high concentrations (20 μg/ml) inhibited both ribonucleic and deoxyribonucleic acid synthesis.

Full text

PDF
376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Candela J. L., García M. C. Effect of actinomycin D and glucagon on glucose uptake by spheroplasts of E. coli. Life Sci. 1970 Feb 22;9(4):235–239. doi: 10.1016/0024-3205(70)90230-4. [DOI] [PubMed] [Google Scholar]
  2. Sawicki S. G., Godman G. C. On the differential cytotoxicity of actinomycin D. J Cell Biol. 1971 Sep;50(3):746–761. doi: 10.1083/jcb.50.3.746. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES